Axsome Therapeutics AXSM
NASDAQ AXSM
$184.39 -1.75 (-0.94%)
At close: Sep 30, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) EV to EBITDA (2015 - 2018)

Updated

Axsome Therapeutics' EV to EBITDA came in at 2.91 for Q1 2018, up 173.7% from 1.06 a year earlier but down 27.3% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) EV to EBITDA (2015 - 2018) Analysis & Trends

Over the trailing twelve months to Mar 31, 2018, Axsome Therapeutics reported EV to EBITDA of -5.47.

  • The five-year range for quarterly EV to EBITDA is 1.06 (Q1 2017) to 9.17 (Q1 2016).
  • Year-over-year, EV to EBITDA increased in two of the last six quarters, with an average decline of 4.0%.
  • Business Quant data shows AXSM's EV to EBITDA at 4.00 (Q4 2017), 3.51 (Q3 2017) and 3.14 (Q2 2017) in the three quarters before Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Axsome Therapeutics 9.74 Bn 8.46 Bn 204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 2.91
Dec 31, 2017 4.00
Sep 30, 2017 3.51
Jun 30, 2017 3.14
Mar 31, 2017 1.06
Dec 31, 2016 3.36
Sep 30, 2016 5.07
Jun 30, 2016 5.90
Mar 31, 2016 9.17
Dec 31, 2015 6.82
API Access

Axsome Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AXSM&period=max&api_key=YOUR_API_KEY